Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 7/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5236256 | 0.82 | KDM4E (0.44) | MEN1PKMKMT2ADGAT1ALDH1A1 | |
| SCHEMBL29333898 | 0.81 | DGAT1 (0.42) | MEN1PKMKMT2ADGAT1ALDH1A1 | |
| SCHEMBL15105948 | 0.81 | PTGDR2 (0.45) | MEN1PKMKMT2ADGAT1MAOA | |
| SCHEMBL5236111 | 0.78 | KMT2A (0.46) | MEN1PKMKMT2AALDH1A1 | |
| SCHEMBL15106217 | 0.78 | GSK3B (0.41) | MEN1PKMKMT2ADGAT1ALDH1A1 | |
| SCHEMBL22979540 | 0.77 | OGG1 (0.42) | MEN1PKMKMT2ADGAT1ALDH1A1 | |
| SCHEMBL28176626 | 0.77 | ALDH1A1 (0.41) | MEN1PKMKMT2AALDH1A1 | |
| SCHEMBL8745851 | 0.74 | SLC6A4 (0.44) | KMT2AALDH1A1 | |
| SCHEMBL392086 | 0.73 | KDM4E (0.50) | MEN1KMT2AALDH1A1 | |
| SCHEMBL29395694 | 0.73 | DGAT1 (0.61) | IDO1MEN1KMT2ADGAT1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-02-22 | — | — | US | disclosed |
| EP-1671941-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | Nissan Chemical Industries, Ltd. (JP) | 2006-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | L3MBTL1, L3MBTL3, L3MBTL4 | IDO1 488/4885MEN1 4633/4885PKM 3543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.